Correlation of different HPV genotype viral loads and cervical lesions: A retrospective analysis of 1585 cases
Open Access
- 18 November 2024
- journal article
- research article
- Published by Wiley in Cancer Cytopathology
- Vol. 133 (1)
Abstract
Background: To reduce unnecessary examinations and treatments, an effective detection method for differentiating human papillomavirus (HPV)‐positive patients is urgently needed. This study aimed to explore the differences in HPV viral loads across various cervical lesions and identify the optimal cutoff value for high‐grade squamous intraepithelial lesions (HSILs).Methods: This retrospective study included patients with varying degrees of cervical lesions admitted to a hospital between January 1, 2023, and March 1, 2024. The HPV genotype and viral load were determined using BioPerfectus multiplex real‐time assay. The differences in HPV genotype viral loads among cervical lesion classifications were analyzed to identify the most applicable type of viral load.Results: The viral loads of HPV16, HPV31, HPV33, HPV35, and HPV58 were significantly associated with the grade of cervical lesions (p < .05), with the HPV16 group exhibiting the strongest correlation (p < .01). The HPV16 viral load demonstrated good sensitivity (Se) and specificity (Sp) for predicting HSIL (Se = 81.52%, Sp = 64.13%). The three most prevalent HPV genotypes associated with negative, low‐grade squamous intraepithelial lesions (LSILs) and HSILs were HPV16, HPV52, and HPV58. HPV33 exhibited the highest prevalence of HSILs, followed by HPV16.Conclusions: High‐risk HPV viral load is associated with cervical lesion classification. HPV16 viral load can effectively differentiate HSIL from LSIL with good Se and Sp.Keywords
This publication has 36 references indexed in Scilit:
- Impact of high‐risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real‐world data from regional cervical cancer screening programJournal of Medical Virology, 2022
- Risk stratification for cervical neoplasia using extended high‐risk HPV genotyping in women with ASC‐US cytology: A large retrospective study from ChinaCancer Cytopathology, 2021
- Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in ChinaJAMA Oncology, 2021
- APOBEC: A molecular driver in cervical cancer pathogenesisCancer Letters, 2021
- Correlation between multi‐type human papillomavirus infections and viral loads and the cervical pathological gradeInternational Journal of Gynecology & Obstetrics, 2020
- Effective methylation triage of HPV positive women with abnormal cytology in a middle‐income countryInternational Journal of Cancer, 2020
- Human papillomavirus vaccine against cervical cancer: Opportunity and challengeCancer Letters, 2020
- Significance of HPV 16 and 18 viral load quantitation in women referred for colposcopyJournal of Medical Virology, 2011
- Human papillomavirus testing and cervical cytology in primary screening for cervical cancer among women in rural China: Comparison of sensitivity, specificity, and frequency of referralInternational Journal of Cancer, 2010
- Integration of high‐risk human papillomavirus: a key event in cervical carcinogenesis?The Journal of Pathology, 2007